Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma (NCT00415454)Henry Ford Health System2006-11-01
Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery (NCT00488423)The Cleveland Clinic2006-11-01
Oral Topotecan to Treat Recurrent or Persistent Solid Tumors (NCT00382733)Accelerated Community Oncology Research Network2006-11-01
A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer (NCT00633087)Rutgers, The State University of New Jersey2006-11-01
Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer (NCT00397293)Ascenta Therapeutics2006-11-01
A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma (NCT00431990)Peter MacCallum Cancer Centre, Australia2006-11-01
Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors (NCT00551512)CanBas Co. Ltd.2006-11-01
Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC) (NCT00401778)Emory University2006-11-01
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma (NCT00407407)Celgene2006-11-01
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia (NCT00886496)Enzon Pharmaceuticals, Inc.2006-11-01
Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation (NCT00428233)Dana-Farber Cancer Institute2006-11-01
Acupuncture for Treatment of Acute Spinal Cord Injury: an Exploratory/Developmental Study (NCT00432289)Craig Hospital2006-11-01
To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin (NCT00442052)POZEN2006-11-01
Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033 (NCT00376285)Pfizer2006-11-01
A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors (NCT00397046)Puma Biotechnology, Inc.2006-11-01
Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer (NCT00622622)Wakayama Medical University2006-11-01
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus (NCT02391259)Amgen2006-11-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes (NCT02212925)Boehringer Ingelheim2006-11-01
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors (NCT00551122)University of Southampton2006-11-01
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies (NCT00449280)University of Chicago2006-11-01
Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Metabolism of a Single Dose of Licarbazepine (NCT00424671)Novartis2006-11-01
Study on Anti-inflammatory Effects of Topical R115866 Gel (NCT00719121)Stiefel, a GSK Company2006-11-01
Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer (NCT00398086)Celgene2006-11-01
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting (NCT00412425)M.D. Anderson Cancer Center2006-11-01
Rituximab for the Treatment of Early Rheumatoid Arthritis (RA) (NCT00396812)National Institute of Allergy and Infectious Diseases (NIAID)2006-11-01
Safety Study on AdCD40L Gene Therapy for Bladder Cancer (NCT00891748)Uppsala University2006-11-01
Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males (NCT00435695)GlaxoSmithKline2006-11-01
A First-in-Human Study of JNJ-28431754 in Healthy Male Volunteers (NCT01177150)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2006-11-01
First in Men Study of Single Oral Doses of ASP1941 in Healthy Subjects (NCT01288885)Astellas Pharma Inc2006-11-01
A Study of ARQ 171 in Patients With Advanced Solid Tumors (NCT00398840)ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)2006-11-01
Diindolylmethane in Healthy Volunteers (NCT00392652)National Cancer Institute (NCI)2006-11-01
A Sequential Dose-Escalation Study in Subjects With Mild Asthma (NCT00512486)MedImmune LLC2006-11-01
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis (NCT00594932)Oklahoma Medical Research Foundation2006-11-01
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer (NCT00753844)Kinki University2006-11-01
A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects (NCT01514825)Astellas Pharma Inc2006-11-01
Phase I/II, Randomized, Double-Blind, Study of the Progenitor Cell Mobilizing Effects of Imprime PGG™ Injection Administered at Varied Dosing Regimens With G-CSF Versus G-CSF Alone (NCT00542529)HiberCell, Inc.2006-11-01
Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women (NCT01508858)Novo Nordisk A/S2006-11-01
Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects (NCT02191657)ApoPharma2006-11-01
Oral Androgens in Man-4: (Short Title: Oral T-4) (NCT00399165)University of Washington2006-11-01
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis. (NCT00417820)Novartis2006-11-01
Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma (NCT00486564)University of Vermont2006-11-01
Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition (NCT01503437)Dr. Reddy's Laboratories Limited2006-11-01
Correlation of 6-Minute Walk Test and Neuromuscular Parameters in the Elderly (NCT00451737)National Taiwan University Hospital2006-11-01
Bioequivalence Study of Atazanavir 300 mg Capsule (NCT00393328)Bristol-Myers Squibb2006-11-01
Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers (NCT00418509)Novartis2006-11-01
Dendritic Cell Vaccine in HIV-1 Infection (NCT00402142)Hospital Clinic of Barcelona2006-11-01
Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions (NCT01264289)Dr. Reddy's Laboratories Limited2006-11-01
Interpersonal Psychotherapy for Depressed Adolescents Engaging in Non-suicidal Self-injury (NCT00401102)New York State Psychiatric Institute2006-11-01
Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg (NCT01020214)Mylan Pharmaceuticals Inc2006-11-01
Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma (NCT00372853)AstraZeneca2006-11-01
Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects. (NCT00417261)Novartis2006-11-01
Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors (NCT00996255)Nerviano Medical Sciences2006-11-01
Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function (NCT00416702)Novartis2006-11-01
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma (NCT00587132)Mayo Clinic2006-11-01
Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) (NCT00379717)Universitair Ziekenhuis Brussel2006-11-01
Supervised Treatment of Schizophrenia, a Randomized Controlled Trial. (NCT00392249)Lady Reading Hospital, Pakistan2006-11-01
PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer (NCT00669292)Wakayama Medical University2006-11-01
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies (NCT00406809)AbbVie (prior sponsor, Abbott)2006-11-01
Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma (NCT00353717)Hadassah Medical Organization2006-11-01
Use of Conjugated Linoleic Acid as a Nutraceutical for Weight Loss in Humans (NCT01047280)University of Manitoba2006-11-01
Tobacco Cessation Treatment for Pregnant Alaska Natives (NCT00379444)Mayo Clinic2006-11-01
A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers (NCT00414999)TargeGen2006-11-01
Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women (NCT00397176)Wyeth is now a wholly owned subsidiary of Pfizer2006-11-01
LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma (NCT00412997)Novartis2006-11-01
DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy (NCT00429806)CHU de Quebec-Universite Laval2006-11-01
A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects (NCT00443170)GlaxoSmithKline2006-11-01
Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1 (NCT00396149)Stallergenes Greer2006-11-01
Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women (NCT00396799)Wyeth is now a wholly owned subsidiary of Pfizer2006-11-01
A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes (NCT00398619)Incyte Corporation2006-11-01
A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers. (NCT00429728)GlaxoSmithKline2006-11-01
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors (NCT00387504)California Cancer Consortium2006-11-01
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer (NCT00537121)Roswell Park Cancer Institute2006-11-01
Prophylactic Antimalarial Activity of DB289 in Volunteers (NCT00408369)Immtech Pharmaceuticals, Inc2006-11-01
Phase I Pediatric FMP2.1/AS02A Trial in Mali (NCT00358332)U.S. Army Medical Research and Development Command2006-11-01
Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors (NCT00424632)Pfizer2006-11-01
Safety Study of PLX4032 in Patients With Solid Tumors (NCT00405587)Plexxikon2006-11-01
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor (NCT00406289)University Hospital, Ghent2006-11-01
PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets (NCT00491998)Vernalis (R&D) Ltd2006-11-01
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine. (NCT02283801)Bial - Portela C S.A.2006-11-01
Clinical Safety of a Novel Milk Protein Peptide (NCT01412658)Ambryx Biotechnology2006-11-01
Exercise Therapy to Treat Adults With Abdominal Aortic Aneurysms (NCT00349947)Stanford University2006-11-01
A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine (NCT00390676)Adherex Technologies, Inc.2006-11-01
Comparison of The Clinical Effects Between Different Physical Therapy Tools in Patellofemoral Pain Patients (NCT00451347)National Taiwan University Hospital2006-11-01
A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers (NCT00411814)GlaxoSmithKline2006-11-01
Intravitreal Bevacizumab in Agioid Streaks (NCT00406250)University of Campania Luigi Vanvitelli2006-11-01
Evaluation of the Effects of Duloxetine on Norepinephrine (NCT00414323)Eli Lilly and Company2006-11-01
Pharmacologic Study of Oseltamivir in Healthy Volunteers (NCT00439530)Mahidol University2006-11-01
Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg (NCT01019590)Mylan Pharmaceuticals Inc2006-11-01
Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function (NCT00418626)Novartis Pharmaceuticals2006-11-01
Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation (NCT00401219)Wyeth is now a wholly owned subsidiary of Pfizer2006-11-01
Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer (NCT00424164)European Organisation for Research and Treatment of Cancer - EORTC2006-11-01
Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma (NCT00476138)Catholic University of the Sacred Heart2006-11-01
Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme (NCT00509301)Peregrine Pharmaceuticals2006-11-01
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies (NCT00120471)National Institute of Allergy and Infectious Diseases (NIAID)2006-11-01
Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (NCT00403156)Vitreous -Retina- Macula Consultants of New York2006-11-01
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors (NCT00423865)Memorial Sloan Kettering Cancer Center2006-11-01
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing (NCT00381173)Eisai Inc.2006-11-01
Visual Feedback Goggle for Positional Vertigo Treatment (NCT00729885)Vertigone Inc.2006-11-01
Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers (NCT00376896)GlaxoSmithKline2006-11-01
A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies (NCT00506402)CASI pharmaceuticals, Inc.2006-11-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.